4.5 Review

Laminin therapy for the promotion of muscle regeneration

Journal

FEBS LETTERS
Volume 589, Issue 22, Pages 3449-3453

Publisher

WILEY
DOI: 10.1016/j.febslet.2015.10.004

Keywords

Laminin; Muscle regeneration; Laminin therapy; Muscular disease; Myoblasts transplantation

Funding

  1. CNPq
  2. CAPES
  3. FAPERJ
  4. Fiocruz (Brazil)
  5. Focem (Mercosur)
  6. Faperj-Sorbonne Universites (Brazil-France)
  7. Association Francaise contre les Myopathies (AFM)
  8. DPP-Nl
  9. EU (FP7 Myoage project) [HEALTH-F2-2009-223576]

Ask authors/readers for more resources

Muscle regeneration is essentially due to activation of satellite cells, which can be isolated and amplified ex vivo, thus representing good candidates for cell therapy. Accumulating data show that the local microenvironment plays a major role during muscle regeneration. In the satellite cell niche, a major extracellular matrix protein is laminin. Human myoblasts transplanted into immunodeficient mice are preferentially located in laminin-enriched areas. Additionally, laminin-111 enhances myoblast proliferation in vitro and increases expression of the alpha 7 beta 1 integrin-type laminin receptor. Intramuscular injection of laminin-111 ameliorates muscular pathology in mdx mice, protecting muscle fibers from damage. Moreover, transplantation of human myoblasts with laminin-111 into Rag/mdx immunodeficient recipients improved efficacy of myoblast transplantation, increasing the number of human dystrophin-positive myofibres. Taken together, these data strongly indicate that exogenous laminin can ameliorate the regeneration process in different models of muscular dystrophies and can be instrumental for improving cell therapy aiming at repairing the degeneration/regeneration process in skeletal muscle. (C) 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Zika virus disrupts gene expression in human myoblasts and myotubes: Relationship with susceptibility to infection

Ingo Riederer, Daniella Areas Mendes-da-Cruz, Guilherme Cordenonsi da Fonseca, Mariela Natacha Gonzalez, Otavio Brustolini, Cassia Rocha, Guilherme Loss, Joseane Biso de Carvalho, Mariane Talon Menezes, Lidiane Menezes Souza Raphael, Alexandra Gerber, Myrna Cristina Bonaldo, Gillian Butler-Browne, Vincent Mouly, Vinicius Cotta-de-Almeida, Wilson Savino, Ana Tereza Ribeiro de Vasconcelos

Summary: This study investigated the mechanisms of Zika virus infection in human skeletal muscle using an in vitro model. The research found that myoblasts are permissive to ZIKV infection, while myotubes control viral replication. Gene expression profiling revealed differences between infected myoblasts and myotubes, with the latter showing pathways related to antiviral and innate immune responses. This study sheds light on potential antiviral mechanisms against ZIKV infection in skeletal muscle.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Article Biochemistry & Molecular Biology

Laminin Triggers Neutrophil Extracellular Traps (NETs) and Modulates NET Release Induced by Leishmania amazonensis

Gustavo Silva-Oliveira, Leandra Linhares-Lacerda, Thayana R. F. Mattos, Camila Sanches, Tatiana Coelho-Sampaio, Ingo Riederer, Elvira M. Saraiva

Summary: Neutrophils release neutrophil extracellular traps (NETs) when they interact with different laminin (LM) isoforms. The induction of NETs by laminins is partially inhibited by anti-alpha 6 integrin antibody and requires elastase and peptidylarginine deiminase (PAD)-4. Laminins also enhance the release of NETs triggered by a protozoan parasite and exhibit leishmanicidal activity.

BIOMEDICINES (2022)

Article Cell Biology

Interaction between mesenchymal stem cells and myoblasts in the context of facioscapulohumeral muscular dystrophy contributes to the disease phenotype

Ekaterina Kiseleva, Olesya Serbina, Anna Karpukhina, Vincent Mouly, Yegor S. Vassetzky

Summary: Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disease caused by the ectopic expression of the DUX4 gene in skeletal muscle, leading to muscle degeneration and replacement by fat and connective tissue. This study demonstrates that the interaction between FSHD myoblasts and MSCs plays a crucial role in the pathophysiology of FSHD, including stimulation of MSC migration, proliferation, and collagen secretion.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

Article Geriatrics & Gerontology

A negative feedback loop between fibroadipogenic progenitors and muscle fibres involving endothelin promotes human muscle fibrosis

Mona Bensalah, Laura Muraine, Alexis Boulinguiez, Lorenzo Giordani, Victorine Albert, Victor Ythier, Jamila Dhiab, Alison Oliver, Valentine Hanique, Teresa Gidaro, Sophie Perie, Jean Lacau St-Guily, Aurelien Corneau, Gillian Butler-Browne, Anne Bigot, Vincent Mouly, Elisa Negroni, Capucine Trollet

Summary: This study explored the role of nonmyogenic cells (fibroadipogenic progenitors, FAPs) in human fibrotic muscles and found that FAPs from fibrotic muscles have a higher proliferation rate compared to those from nonfibrotic muscles, which leads to impaired fusion index when cocultured with muscle cells. The study also identified endothelin as a potential target to counteract human muscle fibrosis through a paracrine signaling pathway.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Cell Biology

Targeting the Ubiquitin-Proteasome System in Limb-Girdle Muscular Dystrophy With CAPN3 Mutations

Jaione Lasa-Elgarresta, Laura Mosqueira-Martin, Klaudia Gonzalez-Imaz, Pablo Marco-Moreno, Gorka Gerenu, Kamel Mamchaoui, Vincent Mouly, Adolfo Lopez de Munain, Ainara Vallejo-Illarramendi

Summary: LGMDR1 is caused by mutations in the CAPN3 gene, leading to reduced SERCA levels. In this study, researchers found that inhibiting the ubiquitin-proteasome pathway can increase SERCA levels and potentially rescue mutant CAPN3 protein. However, treatment with a proteasome inhibitor did not effectively restore SERCA levels in an animal model.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Immunology

Aberrant IL-17 Levels in Rodent Models of Autism Spectrum Disorder: A Systematic Review

Alexandra Jade Thawley, Luciana Peixoto Veneziani, Francisco Diego Rabelo-da-Ponte, Ingo Riederer, Daniella Areas Mendes-da-Cruz, Victorio Bambini-Junior

Summary: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by stereotyped behaviors, specific interests, and impaired communication skills. Elevated levels of pro-inflammatory cytokine IL-17A (IL-17) have been implicated as part of immune alterations in ASD. Studies using rodent models have shown the role of T-cell activation and IL-17 secretion in the pathogenesis of ASD. A systematic review of 28 studies on IL-17 levels in rodent models of ASD found that IL-17 levels were generally increased in different ASD models.

FRONTIERS IN IMMUNOLOGY (2022)

Article Clinical Neurology

Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy

Fanny Roth, Jamila Dhiab, Alexis Boulinguiez, Hadidja-Rose Mouigni, Saskia Lassche, Elisa Negroni, Laura Muraine, Alix Marhic, Alison Oliver, Jeanne Laine, Andree Rouche, Erin K. O'Ferrall, Baziel van Engelen, Coen Ottenheijm, Hagar Greif, Sergiu Blumen, Jean Lacau St Guily, Sophie Perie, Gillian Butler-Browne, Vincent Mouly, Capucine Trollet

Summary: In this study, the authors conducted a comprehensive analysis of PABPN1 aggregates in human muscle biopsy samples. They found that age and genotype influence the formation of PABPN1 aggregates, and identified new components of these aggregates. They also observed larger aggregates in myonuclei and fewer aggregates in the pharyngeal muscle. In addition, they confirmed the presence of PABPN1 aggregates during muscle fiber regeneration using a xenograft model. These findings contribute to our understanding of the pathophysiology of OPMD.

ACTA NEUROPATHOLOGICA (2022)

Correction Cell Biology

Activated dendritic cells modulate proliferation and differentiation of human myoblasts (vol 9, 551, 2018)

Leandro Ladislau, Debora M. Portilho, Tristan Courau, Alhondra Solares-Perez, Elisa Negroni, Jeanne Laine, David Klatzmann, Adriana Bonomo, Yves Allenbach, Olivier Benveniste, Ingo Riederer, Wilson Savino, Vincent Mouly, Gillian Butler-Browne, Claudia F. Benjamim

CELL DEATH & DISEASE (2022)

Article Cell Biology

Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their virtual secretome

Elisa Negroni, Maria Kondili, Laura Muraine, Mona Bensalah, Gillian Sandra Butler-Browne, Vincent Mouly, Anne Bigot, Capucine Trollet

Summary: Skeletal muscle is a highly plastic tissue that participates in the maintenance, regeneration, and repair of muscles through the interaction and communication of heterogeneous cell populations. Fibro-Adipogenic Progenitors (FAPs) are crucial in muscle homeostasis and regeneration, as they interact with other cells and dynamically remodel the extracellular matrix.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Oncology

The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopenia

Anton De Spiegeleer, Evelien Wynendaele, Amelie Descamps, Nathan Debunne, Bart P. Braeckman, Marjan De Mey, Julie Coudenys, Liesbeth Crombez, Frederick Verbeke, Yorick Janssens, Rekin's Janky, Evy Goossens, Caroline Vlaeminck, Dries Duchi, Vanessa Andries, Emilie Dumas, Mirko Petrovic, Tom van de Wiele, Daniel Knappe, Ralf Hoffmann, Vincent Mouly, Anne Bigot, Lars Vereecke, Filip Van Immerseel, Nele van den Noortgate, Bart De Spiegeleer, Dirk Elewaut

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Pharmacology & Pharmacy

Update on anti-fibrotic pharmacotherapies in skeletal muscle disease

Laura Muraine, Mona Bensalah, Gillian Butler -Browne, Anne Bigot, Capucine Trollet, Vincent Mouly, Elisa Negroni

Summary: Fibrosis, the excessive accumulation of extracellular matrix, occurs in many muscle disorders and interferes with muscle regeneration and gene therapies. Slowing down or reversing fibrosis is crucial for maintaining muscle function. Various therapeutic compounds targeting fibrogenic signals have been tested in muscle diseases, particularly in Duchenne Muscular Dystrophy. This review provides an overview of pharmacotherapies tested to reduce fibrosis in skeletal muscle.

CURRENT OPINION IN PHARMACOLOGY (2023)

Article Medicine, Research & Experimental

Nuclear aggregates in oculopharyngeal muscular dystrophy

Alexis Boulinguiez, Fany Roth, Hadidja Rose Mouigni, Gillian Butler-Browne, Vincent Mouly, Capucine Trollet

Summary: This study focuses on the basic research of oculopharyngeal muscular dystrophy (OPMD), which is a disease caused by trinucleotide expansions. The presence of aggregates within muscle fiber nuclei is believed to play a crucial role in the pathogenesis of OPMD. Understanding their composition and deleterious effects can lead to new therapeutic approaches.

M S-MEDECINE SCIENCES (2023)

Article Multidisciplinary Sciences

Endosomal lipid signaling reshapes the endoplasmic reticulum to control mitochondrial function

Wonyul Jang, Dmytro Puchkov, Paula Samso, YongTian Liang, Michal Nadler-Holly, Stephan J. Sigrist, Ulrich Kintscher, Fan Liu, Kamel Mamchaoui, Vincent Mouly, Volker Haucke

Summary: Cells respond to fluctuating nutrient supply by changing organelle dynamics and metabolism. This study reveals that lipid signaling on the endoplasmic reticulum can control mitochondrial morphology and function, enabling cells to adapt to changing nutrient environments.

SCIENCE (2022)

Article Medicine, Research & Experimental

Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene

Cedric Happi Mbakam, Joel Rousseau, Yaoyao Lu, Anne Bigot, Kamel Mamchaoui, Vincent Mouly, Jacques P. Tremblay

Summary: In this study, researchers used CRISPR-Cas9 prime editing technology to correct a mutation in the DMD gene, resulting in improved editing efficiency and restoration of dystrophin protein expression. Optimization of the reverse transcription template sequence led to a significant increase in the editing percentage of the target nucleotide.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

No Data Available